A first-mover opportunity in sustainable marine chemistry
Alka Nova is an early-stage investment opportunity at the intersection of maritime decarbonisation, industrial safety, and sustainable chemistry — a market that is large, underserved, and moving fast.
The opportunity
The global shipping industry is undergoing its most significant regulatory and operational transformation in decades. Alka Nova is positioned at the centre of that shift.
A Massive, Defined Market
Over 50,000 vessels now operate scrubber systems — a number that continues to grow as IMO 2020 sulphur regulations drive adoption. Each vessel requires ongoing alkaline chemical treatment. The market is large, recurring, and captive.
A Real, Unresolved Problem
Caustic soda is the dominant treatment chemical — but it is highly corrosive, hazardous to handle, complex to store and transport, and increasingly misaligned with the sustainability commitments of major shipping operators. No credible alternative has existed — until now.
Regulatory Tailwinds
IMO decarbonisation targets, tightening port-state environmental controls, and growing ESG pressure on shipping companies are all driving demand for safer, more sustainable chemistry. Alka Nova is positioned ahead of this curve.
Market Size Breakdown
Market estimates are indicative and based on publicly available data on scrubber adoption rates and chemical treatment costs. Not a guarantee of future revenues.
Why Alka Nova wins
Novel Chemistry
Alka Nova is not a reformulation of existing products. It is a genuinely novel alkaline chemistry profile — one that delivers the required performance without the hazards. This creates a meaningful, defensible technical differentiation.
First-Mover Advantage
No credible non-caustic alternative for marine scrubber treatment currently exists at commercial scale. Alka Nova has the opportunity to define and own this category before competitors can respond.
Sticky, Recurring Revenue
Chemical treatment is a consumable — vessels need it continuously. Once Alka Nova is qualified and integrated into a vessel's operations, switching costs are high and revenue is predictable and recurring.
Regulatory Alignment
Every major regulatory trend in shipping — IMO decarbonisation, port-state environmental controls, ESG reporting — favours safer, more sustainable chemistry. Alka Nova is positioned with, not against, the direction of travel.
The moat: Novel chemistry formulation + first-mover brand recognition + vessel qualification data + distribution partnerships = a compounding competitive advantage that becomes harder to replicate with every commercial relationship established.
How we make money
Direct Product Sales
Alka Nova sold directly to ship operators and fleet managers as a recurring consumable — replacing their existing caustic soda procurement with a safer, premium-positioned alternative.
Distribution Partnerships
Channel partnerships with marine chemical distributors and ship chandlers — leveraging existing distribution infrastructure to reach the global fleet without building a direct sales force from scratch.
Fleet & OEM Agreements
Long-term supply agreements with major fleet operators and scrubber OEMs — providing predictable, contracted revenue and deep integration into vessel procurement processes.
Development Roadmap
Advanced Formulation
Final chemistry development and laboratory validation of Alka Nova formulation.
Pilot Programme Launch
First commercial pilot with qualified maritime operator — real-world performance data collection.
Regulatory Submission
Submission for relevant maritime chemical approvals and classification society endorsements.
Commercial Launch
Full commercial availability — direct sales and first distribution partnerships activated.
Scale & Expand
Fleet agreements, international distribution, and adjacent product development.
What investment enables
Complete formulation development, independent laboratory validation, and pilot-ready product batches.
Fund the first commercial pilot with a maritime operator — covering product supply, monitoring, and data collection.
Pursue relevant maritime chemical approvals, classification society endorsements, and compliance documentation.
Business development, distribution partner engagement, and early sales infrastructure.
Core operational costs to support the above activities.
Investment Objectives
Return Potential
A 1% share of the serviceable addressable market represents approximately $6M in annual recurring revenue — at margins typical of specialty chemical products.
Early investors benefit from pre-commercial valuation, with exit pathways including strategic acquisition by a major chemical or maritime services group, or a later-stage growth equity round.
Forward-looking statements are illustrative only and not a guarantee of returns. Investment involves risk.
Risks we are managing
We believe in transparency. Every early-stage investment carries risk — here is how we are thinking about the key ones.
Partnership pathways
Financial Investor
Equity investment in Dominga Key LLC at pre-commercial valuation. Suitable for angels, family offices, and early-stage VCs with an interest in maritime sustainability or specialty chemicals.
Request investor packMaritime Operator Partner
Participate in the Alka Nova pilot programme — providing a vessel for real-world testing in exchange for early access, preferential pricing, and co-development input on product specifications.
Discuss pilot participationStrategic Partner
Distribution, supply chain, or technology partnerships that accelerate Alka Nova's route to market. Relevant for marine chemical distributors, ship chandlers, and scrubber OEMs.
Explore partnershipRequest the investor pack
We are actively seeking our first investors and strategic partners. If you are interested in learning more about Alka Nova, we would welcome a conversation.
Submit your details and we will be in touch to share the full investor pack and arrange an introductory call at your convenience.
Important Notice: This page contains forward-looking statements and projections that are illustrative only. They are based on assumptions and estimates that may not prove accurate. Past performance is not indicative of future results. Investment in early-stage companies involves significant risk, including the possible loss of the entire investment. Nothing on this page constitutes financial advice or a solicitation to invest. Prospective investors should conduct their own due diligence and seek independent professional advice before making any investment decision.